REAL WORLD OUTCOMES OF OBINUTUZUMAB MONOTHERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.48_2631
Abstract: 1 (PD-1) on total CD4, total CD8 and T helper cells, and cytotoxic T lymphocyte-associated antigen-4 on total CD4 (P=0.010) and regulatory T cells (P read more here.
Keywords: outcomes obinutuzumab; real world; treatment; monotherapy patients ... See more keywords
Real‐World outcomes of adalimumab in adults with non‐infectious uveitis
Sign Up to like & getrecommendations! Published in 2022 at "Acta Ophthalmologica"
DOI: 10.1111/aos.15120
Abstract: To present real‐world adalimumab (ADA) efficacy and safety outcomes in non‐infectious uveitis (NIU) from a single United Kingdom (UK) tertiary centre. read more here.
Keywords: infectious uveitis; world outcomes; real world; non infectious ... See more keywords
Real‐world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib
Sign Up to like & getrecommendations! Published in 2020 at "European Journal of Haematology"
DOI: 10.1111/ejh.13499
Abstract: Ibrutinib has now been approved for treatment of chronic lymphocytic leukemia (CLL) in both front‐line setting and as later‐line treatment. However, knowledge about the outcomes and adverse events (AE) among patients at a population‐based level… read more here.
Keywords: real world; lymphocytic leukemia; outcomes 205; world outcomes ... See more keywords
Understanding real-world outcomes in patients with NSCLC who progress on 1st-/2nd-generation EGFR TKIs.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e20589
Abstract: e20589Background: Epidermal growth factor receptor (EGFR)tyrosine kinase inhibitors (TKIs) are recommended for patients (pts) with EGFR mutation (EGFRm) positive non-small cell lung cancer (NSCLC).... read more here.
Keywords: real world; outcomes patients; world outcomes; understanding real ... See more keywords
Real-world (RW) outcomes for advanced non-small cell lung cancer (aNSCLC) patients (pts) with EGFR exon 19 deletions (x19del) stratified by deletion size.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.9591
Abstract: 9591Background: EGFR x19dels are well-established targetable drivers in NSCLC. Historically x19dels have been treated as a single group, but it’s unclear whether responses vary for distinct subtype... read more here.
Keywords: real world; advanced non; world outcomes; outcomes advanced ... See more keywords
Real-world outcomes of pembrolizumab plus carboplatin plus paclitaxel or nab-paclitaxel in non-small cell lung cancer (NSCLC).
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e21717
Abstract: e21717Background: Pem+carbo+pac or nab-pac are approved first-line (1L) treatments for metastatic squamous NSCLC since 10/30/2018. Difference in real-world outcomes of these triplet combinations ar... read more here.
Keywords: outcomes pembrolizumab; real world; plus carboplatin; world outcomes ... See more keywords
Real-world outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) who received first- or second-line immunotherapies (IO) in the United States (US).
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.6_suppl.457
Abstract: 457Background: Benefit of IO (PD1 and PD-L1 inhibitors) for mUC was observed in clinical trials but real-world evidence for benefit and clinical outcomes is limited. Methods: This was a retrospecti... read more here.
Keywords: real world; outcomes patients; world outcomes; world ... See more keywords
Corrigendum: Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
Sign Up to like & getrecommendations! Published in 2018 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2017.00257
Abstract: [This corrects the article on p. 213 in vol. 4, PMID: 29238708.]. read more here.
Keywords: real world; outcomes pirfenidone; longitudinal real; world outcomes ... See more keywords